D. E. Shaw & Co. Inc. Has $327,000 Position in Bowhead Specialty Holdings Inc. (NYSE:BOW)

D. E. Shaw & Co. Inc. trimmed its holdings in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 60.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 9,202 shares of the company's stock after selling 14,145 shares during the period. D. E. Shaw & Co. Inc.'s holdings in Bowhead Specialty were worth $327,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Summit Investment Advisors Inc. lifted its holdings in Bowhead Specialty by 66.4% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock valued at $43,000 after purchasing an additional 486 shares during the last quarter. New York State Common Retirement Fund bought a new position in Bowhead Specialty during the 4th quarter valued at about $64,000. US Bancorp DE bought a new position in Bowhead Specialty during the 4th quarter valued at about $76,000. KLP Kapitalforvaltning AS bought a new position in Bowhead Specialty during the 4th quarter valued at about $107,000. Finally, Pictet Asset Management Holding SA bought a new position in Bowhead Specialty during the 4th quarter valued at about $145,000.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on BOW shares. Morgan Stanley lifted their price target on shares of Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. JMP Securities lifted their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. Piper Sandler assumed coverage on shares of Bowhead Specialty in a research note on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 target price for the company. JPMorgan Chase & Co. boosted their target price on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a research note on Friday, May 9th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $39.67.

Bowhead Specialty Price Performance

NYSE BOW traded up $0.13 on Friday, hitting $37.29. 152,033 shares of the stock were exchanged, compared to its average volume of 199,733. The business's fifty day moving average is $39.22 and its 200 day moving average is $35.97. Bowhead Specialty Holdings Inc. has a 52 week low of $23.70 and a 52 week high of $42.29. The company has a market capitalization of $1.22 billion and a PE ratio of 28.47.

Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.01. The company had revenue of $174.85 million during the quarter, compared to the consensus estimate of $105.17 million. Analysts predict that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.